Repligen Corp
RGEN· Nasdaq
RGENRepligen Corp
Filed May 7, 2013 · 10-Q · 37 days after period end · 0001193125-13-203891
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $16.46M | $12.82M | $5.91M |
| Net Income | $2.34M | $1.23M | -$2.03M |
| EPS Diluted | $0.07 | $0.04 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 7, 2013 · 37 d after period end
